Načítá se...
Development of Infliximab Target Concentrations during Induction in Pediatric Crohn’s Disease Patients
OBJECTIVES: Subtherapeutic drug concentrations contribute to both primary and secondary nonresponse to infliximab in children with Crohn’s disease (CD). The aim of this study was to evaluate treatment outcomes and infliximab concentrations at infusions 2 and 3 with an objective to establish inflixim...
Uloženo v:
| Vydáno v: | J Pediatr Gastroenterol Nutr |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6607916/ https://ncbi.nlm.nih.gov/pubmed/31232885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MPG.0000000000002304 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|